Table 1 Patient characteristics
From: Consequences of tumor planning target volume reduction in treatment of T2-T4 laryngeal cancer
Patient | TNM-stage | GTV [cm 3 ] | PTV clinical [cm 3 ] | PTV tight [cm 3 ] |
|---|---|---|---|---|
Group 1 | Patients without positive nodes | |||
T3N0M0 | 6.6 | 92.6 | 49.3 | |
T3N0M0 | 10.2 | 126.5 | 44.7 | |
T2N0 | 8.1 | 105.1 | 51.9 | |
cT2N0 | 3.1 | 76.5 | 34.4 | |
cT2N0M0 | 7.1 | 78 | 39.8 | |
cT3N0M0 | 2.3 | 47.9 | 21.4 | |
T2N0 | 4.4 | 38.2 | 26.7 | |
T4aN0M0 | 26.2 | 145.9 | 92.8 | |
T3N0 | 6.9 | 82.5 | 44.4 | |
T3N0M0 | 14.8 | 122.9 | 66.5 | |
Group 2 | Patients with positive nodes | |||
T4N2c | 20 | 96.7 | 83.6 | |
T2N2cM1 | 9.3 | 30.8 | 20.7 | |
T3n2cM0 | 20.6 | 166.4 | 98.7 | |
T2N2xM1 | 9.1 | 100.8 | 52.9 | |
T2N1 | 8.7 | 98.1 | 44.1 | |
cT2N2bM0 | 9 | 110.7 | 57.6 | |
Average | 10.4 | 95.0 | 51.8 | |